ArticleViruses2026
Molecular Characterisation, Isolation, and Antibody Response to Influenza D Virus in Naturally Infected Cattle.
Article in Viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Influenza D virus (IDV) is a respiratory pathogen affecting the health of cattle, thereby causing economic losses. This study was conducted to detect and isolate IDV, investigate its molecular characteristics, and examine the antibody response to IDV in naturally infected cattle. Real-time RT-PCR was used to analyse 279 nasal swabs and blood sera collected from cattle on farms in the Thrace district of Türkiye, bordering the European Union, for IDV-RNA. One sample from 2020 from a small, family-owned farm (D/OK lineage), two samples from 2021 from an integrated farm (D/OK lineage), and two samples from 2024 (D/Yama2019) from an integrated farm were found to be positive for IDV-RNA. All five samples were collected from farms located in Kırklareli. Positive samples were subjected to virus isolation and phylogenetic analyses. Serum samples were analysed using ELISA and HI tests. Of the 279 samples collected, 1.79% tested positive for IDV-RNA in real-time RT-PCR. Seroprevalence, measured for the first time in Türkiye, was found to be 45.5% and 55.19% by ELISA and HI tests, respectively. Key factors statistically associated with IDV seropositivity included the study year, geographical location, and farm type. Clinically, nasal discharge and cough were the primary symptoms in seropositive animals. Genetic analysis revealed that the 2020-2021 samples clustered within the D/OK lineage, while the 2024 samples belonged to the D/Yama2019 lineage. The findings suggest the co-circulation of multiple IDV strains, although this should be interpreted cautiously given the limited number of sequences in the Thrace region. Considering the lack of an influenza D virus (IDV) vaccine, these findings emphasise the importance of continued surveillance and diagnostic testing of cattle to limit viral spread, protect cattle health, and reduce economic losses associated with IDV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.